National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > United States Capecitabine Market Report 2018

United States Capecitabine Market Report 2018

Goods_sn:gz1

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

United States Capecitabine Market Report 2018

Hard Copy: 3800 USD
PDF Copy (single user): 3800 USD
Enterprise wide License: 7600 USD
Pages: 99
Tables and Figures: 113
Published Date: June 2018
Publisher: QYR Pharma & Healthcare Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

In this report, the United States Capecitabine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Capecitabine in these regions, from 2013 to 2025 (forecast).

United States Capecitabine market competition by top manufacturers/players, with Capecitabine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    Teva
    Mylan
    Hikma
    Hengrui Medicine
    Cipla
    Reliance Group
    Hetero

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    500 mg
    150 mg
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Breast Cancer
    Colorectal Cancer
    Stomach Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Capecitabine Market Report 2018
1 Capecitabine Overview
    1.1 Product Overview and Scope of Capecitabine
    1.2 Classification of Capecitabine by Product Category
        1.2.1 United States Capecitabine Market Size (Sales Volume) Comparison by Type (2013-2025)
        1.2.2 United States Capecitabine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        1.2.3 500 mg
        1.2.4 150 mg
    1.3 United States Capecitabine Market by Application/End Users
        1.3.1 United States Capecitabine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        1.3.2 Breast Cancer
        1.3.3 Colorectal Cancer
        1.3.4 Stomach Cancer
    1.4 United States Capecitabine Market by Region
        1.4.1 United States Capecitabine Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 The West Capecitabine Status and Prospect (2013-2025)
        1.4.3 Southwest Capecitabine Status and Prospect (2013-2025)
        1.4.4 The Middle Atlantic Capecitabine Status and Prospect (2013-2025)
        1.4.5 New England Capecitabine Status and Prospect (2013-2025)
        1.4.6 The South Capecitabine Status and Prospect (2013-2025)
        1.4.7 The Midwest Capecitabine Status and Prospect (2013-2025)
    1.5 United States Market Size (Value and Volume) of Capecitabine (2013-2025)
        1.5.1 United States Capecitabine Sales and Growth Rate (2013-2025)
        1.5.2 United States Capecitabine Revenue and Growth Rate (2013-2025)

2 United States Capecitabine Market Competition by Players/Suppliers
    2.1 United States Capecitabine Sales and Market Share of Key Players/Suppliers (2013-2018)
    2.2 United States Capecitabine Revenue and Share by Players/Suppliers (2013-2018)
    2.3 United States Capecitabine Average Price by Players/Suppliers (2013-2018)
    2.4 United States Capecitabine Market Competitive Situation and Trends
        2.4.1 United States Capecitabine Market Concentration Rate
        2.4.2 United States Capecitabine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Capecitabine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Capecitabine Sales (Volume) and Revenue (Value) by Region (2013-2018)
    3.1 United States Capecitabine Sales and Market Share by Region (2013-2018)
    3.2 United States Capecitabine Revenue and Market Share by Region (2013-2018)
    3.3 United States Capecitabine Price by Region (2013-2018)

4 United States Capecitabine Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
    4.1 United States Capecitabine Sales and Market Share by Type (Product Category) (2013-2018)
    4.2 United States Capecitabine Revenue and Market Share by Type (2013-2018)
    4.3 United States Capecitabine Price by Type (2013-2018)
    4.4 United States Capecitabine Sales Growth Rate by Type (2013-2018)

5 United States Capecitabine Sales (Volume) by Application (2013-2018)
    5.1 United States Capecitabine Sales and Market Share by Application (2013-2018)
    5.2 United States Capecitabine Sales Growth Rate by Application (2013-2018)
    5.3 Market Drivers and Opportunities

6 United States Capecitabine Players/Suppliers Profiles and Sales Data
    6.1 Roche
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Capecitabine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 Teva
        6.2.2 Capecitabine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Teva Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 Mylan
        6.3.2 Capecitabine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    6.4 Hikma
        6.4.2 Capecitabine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.4.4 Main Business/Business Overview
    6.5 Hengrui Medicine
        6.5.2 Capecitabine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.5.4 Main Business/Business Overview
    6.6 Cipla
        6.6.2 Capecitabine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.6.4 Main Business/Business Overview
    6.7 Reliance Group
        6.7.2 Capecitabine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.7.4 Main Business/Business Overview
    6.8 Hetero
        6.8.2 Capecitabine Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2013-2018)
        6.8.4 Main Business/Business Overview

7 Capecitabine Manufacturing Cost Analysis
    7.1 Capecitabine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Capecitabine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Capecitabine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Capecitabine Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Capecitabine Market Size (Value and Volume) Forecast (2018-2025)
    11.1 United States Capecitabine Sales Volume, Revenue Forecast (2018-2025)
    11.2 United States Capecitabine Sales Volume Forecast by Type (2018-2025)
    11.3 United States Capecitabine Sales Volume Forecast by Application (2018-2025)
    11.4 United States Capecitabine Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Capecitabine
    Figure United States Capecitabine Market Size (Kg) by Type (2013-2025)
    Figure United States Capecitabine Sales Volume Market Share by Type (Product Category) in 2017
    Figure 500 mg Product Picture
    Figure 150 mg Product Picture
    Figure United States Capecitabine Market Size (Kg) by Application (2013-2025)
    Figure United States Sales Market Share of Capecitabine by Application in 2017
    Figure Breast Cancer Examples
    Table Key Downstream Customer in Breast Cancer
    Figure Colorectal Cancer Examples
    Table Key Downstream Customer in Colorectal Cancer
    Figure Stomach Cancer Examples
    Table Key Downstream Customer in Stomach Cancer
    Figure United States Capecitabine Market Size (Million USD) by Region (2013-2025)
    Figure The West Capecitabine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southwest Capecitabine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Middle Atlantic Capecitabine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure New England Capecitabine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The South of US Capecitabine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Midwest Capecitabine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Capecitabine Sales (Kg) and Growth Rate (2013-2025)
    Figure United States Capecitabine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Capecitabine Market Major Players Product Sales Volume (Kg) (2013-2018)
    Table United States Capecitabine Sales (Kg) of Key Players/Suppliers (2013-2018)
    Table United States Capecitabine Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Capecitabine Sales Share by Players/Suppliers
    Figure 2017 United States Capecitabine Sales Share by Players/Suppliers
    Figure United States Capecitabine Market Major Players Product Revenue (Million USD) (2013-2018)
    Table United States Capecitabine Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table United States Capecitabine Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Capecitabine Revenue Share by Players/Suppliers
    Figure 2017 United States Capecitabine Revenue Share by Players/Suppliers
    Table United States Market Capecitabine Average Price (USD/g) of Key Players/Suppliers (2013-2018)
    Figure United States Market Capecitabine Average Price (USD/g) of Key Players/Suppliers in 2017
    Figure United States Capecitabine Market Share of Top 3 Players/Suppliers
    Figure United States Capecitabine Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Capecitabine Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Capecitabine Product Category
    Table United States Capecitabine Sales (Kg) by Region (2013-2018)
    Table United States Capecitabine Sales Share by Region (2013-2018)
    Figure United States Capecitabine Sales Share by Region (2013-2018)
    Figure United States Capecitabine Sales Market Share by Region in 2017
    Table United States Capecitabine Revenue (Million USD) and Market Share by Region (2013-2018)
    Table United States Capecitabine Revenue Share by Region (2013-2018)
    Figure United States Capecitabine Revenue Market Share by Region (2013-2018)
    Figure United States Capecitabine Revenue Market Share by Region in 2017
    Table United States Capecitabine Price (USD/g) by Region (2013-2018)
    Table United States Capecitabine Sales (Kg) by Type (2013-2018)
    Table United States Capecitabine Sales Share by Type (2013-2018)
    Figure United States Capecitabine Sales Share by Type (2013-2018)
    Figure United States Capecitabine Sales Market Share by Type in 2017
    Table United States Capecitabine Revenue (Million USD) and Market Share by Type (2013-2018)
    Table United States Capecitabine Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Capecitabine by Type (2013-2018)
    Figure Revenue Market Share of Capecitabine by Type in 2017
    Table United States Capecitabine Price (USD/g) by Types (2013-2018)
    Figure United States Capecitabine Sales Growth Rate by Type (2013-2018)
    Table United States Capecitabine Sales (Kg) by Application (2013-2018)
    Table United States Capecitabine Sales Market Share by Application (2013-2018)
    Figure United States Capecitabine Sales Market Share by Application (2013-2018)
    Figure United States Capecitabine Sales Market Share by Application in 2017
    Table United States Capecitabine Sales Growth Rate by Application (2013-2018)
    Figure United States Capecitabine Sales Growth Rate by Application (2013-2018)
    Table Roche Basic Information List
    Table Roche Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Roche Capecitabine Sales Growth Rate (2013-2018)
    Figure Roche Capecitabine Sales Market Share in United States (2013-2018)
    Figure Roche Capecitabine Revenue Market Share in United States (2013-2018)
    Table Teva Basic Information List
    Table Teva Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Teva Capecitabine Sales Growth Rate (2013-2018)
    Figure Teva Capecitabine Sales Market Share in United States (2013-2018)
    Figure Teva Capecitabine Revenue Market Share in United States (2013-2018)
    Table Mylan Basic Information List
    Table Mylan Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Mylan Capecitabine Sales Growth Rate (2013-2018)
    Figure Mylan Capecitabine Sales Market Share in United States (2013-2018)
    Figure Mylan Capecitabine Revenue Market Share in United States (2013-2018)
    Table Hikma Basic Information List
    Table Hikma Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Hikma Capecitabine Sales Growth Rate (2013-2018)
    Figure Hikma Capecitabine Sales Market Share in United States (2013-2018)
    Figure Hikma Capecitabine Revenue Market Share in United States (2013-2018)
    Table Hengrui Medicine Basic Information List
    Table Hengrui Medicine Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Hengrui Medicine Capecitabine Sales Growth Rate (2013-2018)
    Figure Hengrui Medicine Capecitabine Sales Market Share in United States (2013-2018)
    Figure Hengrui Medicine Capecitabine Revenue Market Share in United States (2013-2018)
    Table Cipla Basic Information List
    Table Cipla Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Cipla Capecitabine Sales Growth Rate (2013-2018)
    Figure Cipla Capecitabine Sales Market Share in United States (2013-2018)
    Figure Cipla Capecitabine Revenue Market Share in United States (2013-2018)
    Table Reliance Group Basic Information List
    Table Reliance Group Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Reliance Group Capecitabine Sales Growth Rate (2013-2018)
    Figure Reliance Group Capecitabine Sales Market Share in United States (2013-2018)
    Figure Reliance Group Capecitabine Revenue Market Share in United States (2013-2018)
    Table Hetero Basic Information List
    Table Hetero Capecitabine Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2013-2018)
    Figure Hetero Capecitabine Sales Growth Rate (2013-2018)
    Figure Hetero Capecitabine Sales Market Share in United States (2013-2018)
    Figure Hetero Capecitabine Revenue Market Share in United States (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Capecitabine
    Figure Manufacturing Process Analysis of Capecitabine
    Figure Capecitabine Industrial Chain Analysis
    Table Raw Materials Sources of Capecitabine Major Players/Suppliers in 2017
    Table Major Buyers of Capecitabine
    Table Distributors/Traders List
    Figure United States Capecitabine Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
    Figure United States Capecitabine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure United States Capecitabine Price (USD/g) Trend Forecast (2018-2025)
    Table United States Capecitabine Sales Volume (Kg) Forecast by Type (2018-2025)
    Figure United States Capecitabine Sales Volume (Kg) Forecast by Type (2018-2025)
    Figure United States Capecitabine Sales Volume (Kg) Forecast by Type in 2025
    Table United States Capecitabine Sales Volume (Kg) Forecast by Application (2018-2025)
    Figure United States Capecitabine Sales Volume (Kg) Forecast by Application (2018-2025)
    Figure United States Capecitabine Sales Volume (Kg) Forecast by Application in 2025
    Table United States Capecitabine Sales Volume (Kg) Forecast by Region (2018-2025)
    Table United States Capecitabine Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Capecitabine Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Capecitabine Sales Volume Share Forecast by Region in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Request sample If you need any reports sample, just let us know.